| Mike Zaman | |
| Keywords : abbott, abbott laboratories, abt, androgel, erectile dysfunction, fda, hypogonadal men, hypogonadism, low testosterone, nyse:abt, sexual desire, testosterone levels, u.s. food and drug administration, stocks, forest products, grows trees, harvests trees, nyse:wy, timberlan | |
| H1 tags : ; | |
| H2 tags : Abbott Receives U.S. FDA Approval for AndroGel® 1.62% to Treat Men with Low Testosterone; Weyerhaeuser Reports First Quarter Results; Ancestry.com Inc. Announces New $125 Million Share Repurchase Program; Ancestry.com Inc. Reports First Quarter 2011 Financial Results; Lithium Exploration Group Expands Strategy with Argentine Asset |
| Last Update : | 06/October/2011 |
| Google PR : | N/A |
| Indexed pages : | 118 |
| Internal links : | 4 |
| External links : | 46 |
| Archive : | Check how did the site look in the past? |